CPhI Names "Medical Futurist" as First CPhI North America 2018 Keynote Speaker

Feb 07, 2018
By BioPharm International Editors

CPhI, a provider of exhibitions, conferences ,and online communities for the pharma industry, has announced in a Feb. 6, 2018 press release that Dr. Bertalan Mesko, director of The Medical Futurist Institute and author of My Health: Upgraded and The Guide to the Future of Medicine, will present a keynote address at the second annual CPhI North America Conference, which will take place Apr. 24–26, 2018 at the Pennsylvania Convention Center in Philadelphia, PA.

According to CPhI, Dr. Mesko, who holds a PhD in genomics, will focus his keynote presentation on the role of science fiction in the progression of healthcare, patient centricity in the development of new technologies, new challenges presented by patients finding an unregulated, technological solution for health problems, and the cultural impact of highly personalized, digitized health solutions.

Dr. Mesko’s keynote takes place on Apr. 24, 2018 at 1:30pm­ and is open to all conference pass, exhibitors, expo only, and VIP attendees.

“We’re thrilled to have Bertalan Mesko joining us to provide his uniquely entertaining, highly informative and expert visionary insight into the future of research, diagnostics, personalized healthcare, and technology, and how these elements continue to intersect at an increased rate,” commented Joseph Marks, brand director for CPhI North America, in a company press release.

“I’m excited to have the opportunity to connect with CPhI North America and share the latest thinking that underscores the work that we’ve been doing at The Medical Futurist Institute,” added Dr. Mesko in the press release. “We’re in a dynamic era where advanced medical technologies, disruptive innovations, and digital communication are empowering patients to become more informed and, as a result, involved in making decisions relating to their health. Digitalization can make personalized care affordable and available, ensuring sustainability and growing our understanding of disease, and advanced diagnostics promote a focus on prevention rather than simply looking at cures.”

The 2018 conference will have three designated tracks of programming, with two tracks dedicated to pharmaceutical manufacturing, outsourcing, R&D, drug delivery, and supply chain-related topics for small- and large- molecule finished drugs, and one track dedicated to advancements in bio-manufacturing.

The agenda focus includes discussions on pharmaceutical manufacturing, outsourcing, R&D, drug delivery, and supply chain-related topics for small- and large-molecule finished drugs, biopharmaceuticals, and biosimilars/biogenerics, and will explore developments in the following areas:

  • emerging technologies for novel drug delivery systems
  • R&D innovation
  • regulatory developments
  • continuous manufacturing advancements
  • process development
  • tech transfer
  • quality metrics/supply chain best practices
  • bio-manufacturing opportunities and challenges.

The conference will also feature two new zones: a bioprocessing zone and the P-MEC zone­­, a machinery zone to promote the latest technology in manufacturing equipment­. The program schedule will feature more than 30 sessions presented by industry figures.

In addition to the conference program, a series of insight briefings and seminars on technical and business topics will be freely accessible to all exhibition visitors, according to CPhI. Topics include accelerated drug approval programs, the digital transformation of the pharmaceutical industry, supply chain security advancements, and more. There will also be a number of free exhibitor showcases taking place, providing a platform for industry professionals to present progressive perspectives on their products, innovations, and services. Additionally, the conference’s pharmaceutical serialization series will provide a forum for presenters to discuss the latest insights and developments within the serialization sector.

Source: CPhI North America

native1_300x100
lorem ipsum